Diagnósticos y riesgos a largo plazo | 01 SEP 04

Consenso de poliquistosis ovárica

Se realizó en el 2003 un consenso en Rotterdam donde se actualizaron los criterios diagnóstico del síndrome de ovario poliquístico.
Autor/a: Grupo de Trabajo para el Consenso de poliquistosis ovárica de Rotterdam ESHRE/ASRM. Fuente: Consenso de poliquistosis ovárica de Rotterdam ESHRE/ASRM Fertility and Sterility - January 2004 (Vol. 81, Issue 1)

1. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific 1992:377-384

2. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876-1880 MEDLINE

3. Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, et al. PCOS/Troglitazone Study Group. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab. 2001;86:1626-1632 MEDLINE

4. Chang RJ, Katz SE. Diagnosis of polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28:397-408 MEDLINE

5. Laven JS, Imani B, Eijkemans MJ, Fauser BC. New approaches to PCOS and other forms of anovulation. Obstet Gynecol Surv. 2002;57:755-767 MEDLINE

6. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165-169 MEDLINE

7. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141-146 MEDLINE

8. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J. 1986;293:355-359

9. Franks S. Polycystic ovary syndrome: a changing perspective (review). Clin Endocrinol. 1989;31:87-120 MEDLINE

10. Carmina E, Lobo RA. Polycystic ovaries in hirsute women with normal menses. Am J Med. 2001;111:602-606 Abstract | MEDLINE

11. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab. 1987;65:499-507 MEDLINE

12. Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol. 1993;39:351-355 MEDLINE

13. Carey AH, Chan KL, Short F, White D, Williamson R, Franks S. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol. 1993;38:653-658 MEDLINE

14. Legro RS, Driscoll D, Strauss III JF, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA. 1998;95:14956-14960 MEDLINE

15. Azziz R, Hincapie LA, Knochenhauer ES, Dewailly D, Fox L, Boots LR. Screening for 21-hydroxylase deficient non-classic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril. 1999;72:915-925 Abstract | MEDLINE

16. ESHRE Capri Workshop Group . Anovulatory infertility. Hum Reprod. 1995;10:1549-1553 MEDLINE

17. Rowe PJ, Comhaire FH, Hargreave TB. Female partner. In: World Health Organization manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press, 2000:40-67

18. Van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropin infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of PCOS. Fertil Steril. 1997;67:452-458 MEDLINE

19. Moller DE, Cohen O, Yamaguchi Y, Azziz R, Grigorescu F, Eberle A, et al. Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes. 1994;43:247-255 MEDLINE

20. Kreisberg RA. Clinical problem-solving. Half a loaf. N Engl J Med. 1994;330:1295-1299 MEDLINE

21. Waggoner W, Boots LR, Azziz R. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. Gynecol Endocrinol. 1999;13:394-400 MEDLINE

22. Pache TD, Chadha S, Gooren LJ, Hop WC, Jaarsma KW, Dommerholt HB, et al. Ovarian morphology in long-term androgen-treated female-to-male transsexuals. A human model for the study of PCOS?. Histopathology. 1991;19:445-452 MEDLINE

23. Diamanti-Kandarakis E, Koulie CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: a hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006-4011 MEDLINE

24. Carmina E, Koyama T, Chang L, Stanczyk FZ, Lobo RA. Does ethnicity influence the prevalence of adrenal hyperandrogenism in insulin resistance in the polycystic ovary syndrome?. Am J Obstet Gynecol. 1992;167:1807-1812 MEDLINE

25. Ruutiainen K, Erkkola R, Gronroos MA, Irjala K. Influence of body mass index and age on the grade of hair growth in hirsute women of reproductive ages. Fertil Steril. 1998;50:260-265 MEDLINE

26. Slayden SM, Moran C, Sams Jr WM, Boots LR, Azziz R. Hyperandrogenemia in patients presenting with acne. Fertil Steril. 2001;75:889-892 Abstract | MEDLINE

27. Futterweit W, Dunaif A, Yeh C, Kingsley P. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Med Acad Dermatol. 1988;19:831-836

28. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women in the Southeastern United States: a prospective study. J Clin Endocrinol Metab. 1988;83:3078-3082 MEDLINE

29. Pugeat M, Nicolas MH, Craves JC, Alvarado-Dubost C, Fimbel S, Cechaud H, et al. Androgens in polycystic ovarian syndrome. Ann NY Acad Sci. 1993;687:124-135 MEDLINE

30. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10:2107-2111 MEDLINE

31. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434-2438 MEDLINE

32. Boots LR, Potter S, Potter HD, Azziz R. Mea



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023